Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC
Clinical trial NCT04819399 · UNKNOWN
Trial details
- NCT number
- NCT04819399
- Sponsor
- Lindis Biotech GmbH
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-07
- Primary completion
- 2022-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.